NCT04874740View on ClinicalTrials.gov

Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2021

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
COVID-19 PandemicTransplantation, Kidney
Interventions
OTHER

No intervention

No intervention

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER